Number of employees of Ablynx 2013-2017
This statistic illustrates the number of employees of Ablynx from 2013 to 2017. Ablynx is a Belgian biopharmaceutical company engaged in the discovery and the development of nanobodies. In 2018, the French pharmaceutical company Sanofi acquired Ablynx for 3.9 billion euros. As of 2017, Ablynx had approximately 440 employees, which is an increase compared to the previous years.
